JENNAH CUTTING: Open Payments
NPI 1184161622 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 55 payments from 16 companies in 2025. Trend: 2023 $2,336 · 2024 $2,415 · 2025 $1,172
Food & beverage: $1,057Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $335 |
| Otsuka America Pharmaceutical, Inc. | 6 | $121 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| ABBVIE INC. | 6 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| Bausch Health US, LLC | 3 | $57 |
| Neos Therapeutics, LP | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
Products named: HETLIOZ, SPRAVATO, REXULTI, VRAYLAR, FANAPT, CAPLYTA, Auvelity, Adzenys XR-ODT.
Industry payments across GA — which companies pay providers there.
